People on sodium-glucose cotransporter2 (SGLT2) inhibitors were twice as likely to require a lower limb amputation as people taking another type of diabetes medication, Scandinavian researchers have found.



from WebMD Health https://ift.tt/2z9CwRh

0 comments:

Post a Comment

Popular Posts